已收盘 11-13 16:00:00 美东时间
+4.230
+2.81%
今日重点评级关注:Ascendiant Capital:维持NRX Pharmaceuticals"买入"评级,目标价从50美元升至51美元;HC Wainwright & Co.:上调伊诺维奥制药评级至"买入",目标价5美元
11-03 18:20
Truist Securities analyst Jamie Cook reiterates SPX Technologies (NYSE:SPXC) with a Buy and lowers the price target from $266 to $233.
11-03 00:11
华盛资讯10月30日讯,SPX Technologies公布2026财年Q3业绩,公司Q3营收7.15亿美元,同比增长20.5%,归母净利润0.82亿美元,同比增长30.6%。
10-30 18:49
华盛资讯10月30日讯,SPX Technologies公布2026财年Q3业绩,公司Q3营收7.14亿美元,同比增长20.5%,归母净利润0.82亿美元,同比增长30.6%。
10-30 05:51
SPX Technologies (NYSE:SPXC) narrows FY2026 Adj EPS guidance from $8.20-$8.60 to $8.20-$8.50 vs $8.35 analyst estimate. Raises FY2026 sales outlook from $2.705 billion-$2.765 billion to $2.745 billion-$2.805 billion vs $2.759 billion estimate.
10-30 04:09
今日重点评级关注:Jones Trading:维持Rapport Therapeutics"买入"评级,目标价从50美元升至82美元;摩根大通:维持SpaceX"超配"评级,目标价从240美元升至500美元
10-22 11:59
Oppenheimer analyst Bryan Blair maintains SPX Technologies (NYSE:SPXC) with a Outperform and lowers the price target from $270 to $265.
10-22 01:09
今日重点评级关注:巴克莱:上调Vertical Aerospace评级至"标配",目标价从2美元降至1美元;巴克莱:维持Bitdeer Technologies"超配"评级,目标价从15美元升至17美元
10-12 14:52
JP Morgan analyst Stephen Tusa maintains SPX Technologies (NYSE:SPXC) with a Overweight and lowers the price target from $282 to $225.
10-10 04:13